Vibeke Krüse
University of Antwerp(BE)Antwerp University Hospital(BE)Vlaamse Vereniging voor Obstetrie en Gynaecolo(BE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses
Most-Cited Works
- → The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy(2017)272 cited
- → Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial(2017)182 cited
- → Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours(2012)157 cited
- → Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors(2023)89 cited
- → Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?(2019)78 cited
- → A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases(2020)70 cited